Preclinical Evaluation of a ⁶⁴Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma

Although the concept of theranostics is neither new nor exclusive to nuclear medicine, it is a particularly promising approach for the future of nuclear oncology. This approach is based on the use of molecules targeting specific biomarkers in the tumour or its microenvironment, associated with optim...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, Catherine Chauvet, Séverine Marionneau-Lambot, Peter O. Hofgaard, Bjarne Bogen, Julie Pineau, Nathalie Le Bris, Raphaël Tripier, Cyrille Alliot, Férid Haddad, Michel Chérel, Nicolas Chouin, Alain Faivre-Chauvet, Latifa Rbah-Vidal
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2023-06-01
Sarja:	Pharmaceutics
Aiheet:	theranostics copper-64 PET imaging targeted radionuclide therapy dosimetry CD138
Linkit:	https://www.mdpi.com/1999-4923/15/7/1817
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!